Table 3.
Prevalence of clustered CRFs among participants in the GGT <75th and GGT ≥75th percentiles by gender and age. Data are presented as N (percent prevalence).
| Clustered CRFs | Men | P-valuea | Women | P-valueb | ||
|---|---|---|---|---|---|---|
| GGT <75th | GGT ≥75th | GGT <75th | GGT ≥75th | |||
| 0 risk factors | ||||||
| overall | 1815 (22.6%) | 122 (4.6%) | <0.001 | 4379 (48.6%) | 554 (17.5%) | <0.001 |
| ≥1 risk factors | ||||||
| overall | 6227 (77.4%) | 2551 (95.4%) | <0.001 | 4638 (51.4%) | 2611 (82.5%) | <0.001 |
| Age, y | ||||||
| 18–34 | 1871 (61.4%) | 562 (93.7%) | <0.001 | 836 (25.2%) | 177 (52.8%) | <0.001 |
| 35–44 | 1111 (84.2%) | 763 (97.3%) | <0.001 | 980 (48.4%) | 504 (74.4%) | <0.001 |
| 45–54 | 1091 (89.0%) | 659 (96.1%) | <0.001 | 1106 (72.5%) | 747 (87.1%) | <0.001 |
| 55–64 | 1121 (88.8%) | 348 (95.6%) | <0.001 | 1024 (83.7%) | 712 (93.2%) | <0.001 |
| ≥65 | 1033 (87.1%) | 219 (91.6%) | 0.050 | 692 (84.3%) | 471 (93.8%) | <0.001 |
| ≥2 risk factors | ||||||
| overall | 3492 (43.4%) | 2122 (79.4%) | <0.001 | 1905 (21.1%) | 1659 (52.4%) | <0.001 |
| Age, y | ||||||
| 18–34 | 679 (22. 3%) | 451 (75.2%) | <0.001 | 132 (4.0%) | 70 (20.9%) | <0.001 |
| 35–44 | 662 (50.2%) | 638 (81.4%) | <0.001 | 315 (15.6%) | 261 (38.6%) | <0.001 |
| 45–54 | 713 (58.2%) | 568 (82.8%) | <0.001 | 503 (33.0%) | 455 (53.0%) | <0.001 |
| 55–64 | 756 (59.9%) | 293 (80.5%) | <0.001 | 548 (44.8%) | 518 (67.8%) | <0.001 |
| ≥65 | 682 (57.5%) | 172 (72.0%) | <0.001 | 407 (49.6%) | 355 (70.7%) | <0.001 |
| ≥3 risk factors | ||||||
| overall | 1344 (16.7%) | 1252 (46.8%) | <0.001 | 526 (5.8%) | 682 (21.5%) | 0.001 |
| Age, y | ||||||
| 18–34 | 176 (5.8%) | 251 (41.8%) | <0.001 | 10 (0.3%) | 19 (5.7%) | <0.001 |
| 35–44 | 236 (17.9%) | 383 (48.9%) | <0.001 | 60 (3.0%) | 91 (13.4%) | <0.001 |
| 45–54 | 302 (24.6%) | 352 (51.3%) | <0.001 | 130 (8.5%) | 163 (19.0%) | <0.001 |
| 55–64 | 335 (26.5%) | 172 (47.3%) | <0.001 | 180 (14.7%) | 227 (29.7%) | <0.001 |
| ≥65 | 295 (24.9%) | 94 (39.3%) | <0.001 | 146 (17.8%) | 182 (36.3%) | <0.001 |
aGGT <75th vs. GGT ≥75th in men; bGGT <75th vs. GGT ≥75th in women.